September 20, 2018 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Early Access to IsoPlexis’ Single Cell Analytics Platform Enhances Cell Therapy Program at World-renowned Research and Treatment Center

IsoPlexis’ groundbreaking platform has been shown in key studies to predict patient response to cell therapy The IsoLight® platform: • profiles responses at the single cell level enabling researchers to generate a precise functional patient signature to help predict and understand complex patient response to cancer immunotherapies • advances high-need areas of cell therapy research,... Read more

September 19, 2018 M&A, Partnerships Materials Analysis

Covalent Metrology Announces Collaboration with EDAX

Wednesday, September 19, 2018 JOIN THE CONVERSATION For Further Information Contact: Sue Arnell, sue.arnell@ametek.com, 201-529-4880 Covalent Metrology Announces Collaboration with EDAX, Inc. Mahwah, NJ, and Sunnyvale, CA – Covalent Metrology, an innovative, new analytical service lab based in Silicon Valley, announced today that it will collaborate with EDAX, Inc., a business unit of AMETEK, Inc., on the... Read more

September 18, 2018 Informatics & Software Lab Top-10 M&A, Partnerships

BioBright and Beckman Coulter Announce a Strategic Partnership to Bring Enhanced Technical Support Capabilities to Instruments

September 18, 2018 09:00 AM Eastern Daylight Time – BOSTON & INDIANAPOLIS–(BUSINESS WIRE)–BioBright and Beckman Coulter announce a strategic partnership to bring enhanced technical support capabilities to instruments. BioBright’s DarwinSync platform gives Beckman Coulter access to a large amount of precise data about deployed instrument logs, enabling faster troubleshooting, reduced equipment downtime, and predictive analytics.... Read more

September 17, 2018 Bio/Pharma/CRO Informatics & Software M&A, Partnerships

Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research

NEW YORK; Sept. 17, 2018 – Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development. The new research platform,... Read more

September 17, 2018 M&A, Partnerships

BeiGene Selects GE Healthcare’s Off-the-Shelf Biologics Factory to Boost its Manufacturing Capacity for Cancer Drugs

  BeiGene to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies  CHALFONT ST. GILES, UK and BEIJING, CHINA – 18 September 2018 – BeiGene, Ltd., a commercial https://www.ge.com/news/press-releases/beigene-selects-ge-healthcares-shelf-biologics-factory-boost-its-manufacturing Read more

September 17, 2018 M&A, Partnerships

BeiGene Selects GE Healthcare’s Off-the-Shelf Biologics Factory to Boost its Manufacturing Capacity for Cancer Drugs

CHALFONT ST. GILES, UK and BEIJING, CHINA – 18 September 2018 – BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, has selected GE Healthcare Life Sciences’ off-the-shelf biomanufacturing facility, KUBio for large-scale production of its cancer monoclonal antibodies (mAbs).    http://www.genewsroom.com/press-releases/beigene-selects-ge-healthcare%E2%80%99s-shelf-biologics-factory-boost-its-manufacturing Read more

September 17, 2018 M&A, Partnerships

BeiGene Selects GE Healthcare's Off-the-Shelf Biologics Factory to Boost its Manufacturing Capacity for Cancer Drugs

  BeiGene to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies   CHALFONT ST. GILES, UK and BEIJING, CHINA – 18 September 2018 – BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs... Read more

September 16, 2018 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

QIAGEN and NeuMoDx announce strategic partnership to offer next-generation systems for fully integrated molecular diagnostic testing

Hilden, Germany, and Ann Arbor, Michigan, September 17, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced a strategic partnership to commercialize two new fully integrated systems for automation of PCR (polymerase chain reaction) testing. These next-generation systems are specifically designed to help clinical molecular diagnostic laboratories process... Read more

September 14, 2018 Bio/Pharma/CRO Life Science Tools M&A, Partnerships

Horizon Discovery Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform

Location: Cambridge, UK 14/09/2018 AstraZeneca joins Horizon’s Genomics Discovery Initiative CRISPR knockout and activation libraries are a key toolset in early research crRNA libraries are an efficient and convenient platform for gain- and loss-of-function studies Cambridge, UK, 14 September 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene... Read more

September 13, 2018 M&A, Partnerships

Pall Corporation and Aetos Biologics Partner to Deliver Integrated, Off-the-Shelf Biosimilar Manufacturing Solutions

PORT WASHINGTON, N.Y., Sept. 12, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company. The companies will collaborate to offer biosimilar manufacturing solutions to the global biosimilars market. Pall Biotech will... Read more